The structure was published by Ganesan, R., Jelakovic, S., Mittl, P.R., Caflisch, A., and Grutter, M.G., in 2011 in a paper entitled "In Silico Identification and Crystal Structure Validation of Caspase-3 Inhibitors without a P1 Aspartic Acid Moiety." (abstract).
This crystal structure was determined using X-ray diffraction at a resolution of 1.54 Å and deposited in 2010.
The experimental data on which the structure is based was also deposited.
This PDB entry contains a complex of 2 biomacromolecules, namely CASPASE-3 SUBUNIT P17 and CASPASE-3 SUBUNIT P12.
It also contains one or more heterogenic compounds (e.g., ligands, co-factors, ions, modified amino acids, etc.); see here for a complete list.
The molecule most likely forms heterotetramers.
The following tables show cross-reference information to other databases (to obtain a list of all PDB entries sharing the same property or classification, click on the magnifying glass icon):
This entry contains 1 unique UniProt protein: